Search: id:"swepub:oai:DiVA.org:umu-7257" >
PsoReg :
Abstract
Subject headings
Close
- With the introduction of new systemic drugs for the management of psoriasis, we felt an obligation in Sweden to establish a trusted tool to monitor their use. We formed PsoReg to create a solid, long-term database in order to analyze safety and effectiveness of different systemic psoriasis treatment regimens. PsoReg will provide information to help clinicians individualize therapy on a rational basis through evaluation of effectiveness and adverse effects in specific patient subgroups. Designed and managed by specialized health care professionals, PsoReg will enroll all psoriasis patients on systemic treatment to allow a fair comparison of old versus new-generation psoriasis treatments. PsoReg will even create benchmark data for quality assurance of the medical service. A web-based design allows real-time pharmacovigilance and enables the registry to assist clinicians in their day-to-day management of psoriasis patients. In this way PsoReg can become an integrated part of tomorrow’s dermatology.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Dermatologi och venereologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Dermatology and Venereal Diseases (hsv//eng)
Keyword
- Benchmarking
- Databases as Topic
- Dermatologic Agents/adverse effects/therapeutic use
- Humans
- PUVA Therapy
- Phototherapy
- Psoriasis/*therapy
- Quality Assurance; Health Care/*methods
- Registries
- Sweden
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database